Chemotherapy
Amgen Announces Update To U.S. Prescribing Information for Aranesp and EPOGEN
Published in Blood Weekly, March 29th, 2007
Cardiovascular events and tumor progression have been moved to the "Warnings" section from the "Precautions" section of all ESA labels.
The new boxed warning also states that ESAs increased the risk of death when administered to target a hemoglobin of 12 g/dL in patients with active malignant disease receiving neither chemotherapy nor radiation therapy. ESAs are not indicated for this population. In addition, for patients receiving ESAs pre-operatively for reduction of allogeneic blood...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-03-29)
More Articles from Blood Weekly
- Stem Cell Research
Stem Cell Finding Could Help Reduce Transplant Rejection - Biomedical Engineering
Verax Biomedical Submits 510(k) Application to FDA for Platelet PGD Test - Erythropoiesis
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs) - Blood Components
New blood components research from Ruhr University outlined - Sepsis Epidemiology
New sepsis epidemiology study results reported from Karolinska Institut - Tissue Banking
Research from University of Leicester, Faculty of Law provide new insights into tissue banking in children - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
